Cefnus 500mg/250mg Injection
Marketer
Granmed Pharma
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Cefnus 500mg/250mg Injection
Combiflox, a 500mg/250mg injectable antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be solely under a healthcare provider's guidance. Consistent adherence to the prescribed regimen is crucial; premature cessation can compromise its effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) demand prompt medical help. Inform your physician of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness mandates driving cessation. Rest, nutrition, and hydration support optimal recovery. Your doctor may order tests to monitor treatment efficacy.
Uses of Cefnus 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Cefnus 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefnus 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefnus 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cefnus 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefnus 500mg/250mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol ingestion alongside Cefnus 500mg/250mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefnus 500mg/250mg is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
Administering Cefnus 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Cefnus 500mg/250mg Injection may induce drowsiness, visual disturbances, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Cefnus 500mg/250mg Injection use in individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Patients with severe hepatic impairment should use Cefnus 500mg/250mg Injection cautiously, potentially requiring dosage modification. Mild to moderate liver dysfunction does not necessitate Cefnus 500mg/250mg Injection dose alteration; however, physician consultation is advised.
What if you forget to take Cefnus 500mg/250mg Injection :
Should you forget a scheduled dose of Cefnus 500mg/250mg Injection, seek medical advice.
Facts to Know About Cefnus 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently